Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1999-06-29
2000-12-26
Barts, Samuel
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514539, 514562, 560 10, 560 12, 560 16, 562420, 562427, 562429, A61K 3121
Patent
active
061660728
ABSTRACT:
Described herein are compounds having the general formula: ##STR1## wherein: Ar.sup.1 and Ar.sup.2 are independently selected aryl groups, optionally substituted with substituents selected from the group consisting of alkyl, cycloalkyl, alkoxy, alkanoyl, aralkyl, aralkyloxy, halo, NO.sub.2, Ph, CF.sub.3, CN, OH, methylenedioxy, ethylenedioxy, SO.sub.2 NRR', NRR', CO.sub.2 R (where R and R' are independently selected from the group consisting of H and alkyl) and a second aryl group, which may be substituted as above;
wherein any cycloalkyl or aryl substituent is linked to Ar.sup.1 or Ar.sup.2 by a bridging element which may be a single bond, a vinylene group, an ethynylene group, a Z group, a --Z--(CH.sub.2).sub.n -- group, a --(CH.sub.2).sub.n --Z-- group, or a --Z--(CH.sub.2).sub.n --Z-- group, where Z represents an O atom, a S atom, an NH group or an N-alkyl group, and n is an integer from 1 to 4;
wherein Ar.sup.1 and Ar.sup.2 may be attached to the central atom to which they are connected by a single bond, an alkylene, alkenylene or alkynylene group;
wherein Ar.sup.1 and Ar.sup.2 may be attached to the central atom to which they are connected by a single bond, an alkylene, alkenylene or alkynylene group;
R.sup.3 is selected from the group consisting of H and aryl, which may be substituted as for Ar.sup.1 ;
R.sup.4 and R.sup.5 are independently selected from the group consisting of H, alkyl, alkanoyl, benzoyl and benzyl.
REFERENCES:
patent: 3624143 (1971-11-01), Shen et al.
Chem Abstracts Online Printout 1976:90549, rn=5191-80-0;5575-08-6(month unavailable), 1975.
Angelo Fontana, Selective Removal of Sulphur Protecting Groups of Cysteine Residues by Sulphenyl Halides, J.C.S. Chem. Comm, pp. 976-977 (1975).
Zee-Cheng and Cheng, "Experimental Antileukemic Agents. Preparation and Structure-Activity Study of S-Tritylcysteine and Related Compounds", J. Med. Chem., 13:414-418, 1970.
Zee-Cheng and Cheng, "Structural Modification of S-Trityl-L-cysteine. Preparation of Some S-(Substituted Trityl)-L-cysteines and Dipeptides of S-Trityl-L-cysteine", J. Med. Chem., 15:13-16, 1972.
Dhar et al., "Design, Synthesis and Evaluation of Substituted Triarylnipecotic Acid Derivatives as GABA Uptake Inhibitors: Identification of a Ligand with Moderate Affinity and Selectivity for the Cloned Human GABA Transporter GAT-3", J. Med. Chem., 37:2334-2342, 1994.
Photaki et al., "On Cysteine and Cystine Peptides. Part V. S-Trityl-and S-Diphenyl-methyl-cysteine and -cysteine Peptides", J. Chem. Soc. (C), 2683-2687, 1970.
Pless, "Properties and suitability of the 10, 11-dihydro-5 H-dibenzo[a, d]cyclohepten-5-yl-group (=5-dibenzosuberyl group) as a new protecting group for amines, amino-acids, alcohols, thiols andcarboxylic acids", Helvetica Chemica Acta, 59:499-512, 1976.
Zervas and Photaki, "On Cystein and Cystine Peptides. I. New S-Protecting Groups for Cysteine", J. Am. Chem. Soc., 84: 3887-3897, 1962.
Bell Stanley Charles
De Vivo Michael
Hopper Allen
Isaac Methvin
O'Brien Anne
Allelix Neuroscience Inc.
Barts Samuel
LandOfFree
Amino acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-995451